| Sign In to gain access to subscriptions and/or personal tools. |
High-Throughput Screening for Small-Molecule Inhibitors of LARG-Stimulated RhoA Nucleotide Binding via a Novel Fluorescence Polarization Assay
* To whom correspondence should be addressed. E-mail: Rneubig{at}umich.edu.
S (BODIPY-TR-GTP S), the authors performed a 10,000-compound high-throughput screen for inhibitors of LARG-stimulated RhoA nucleotide binding. Five compounds identified from the high-throughput screen were confirmed in a nonfluorescent radioactive guanine nucleotide-binding assay measuring LARG-stimulated [35S] GTP S binding to RhoA, thus ruling out nonspecific fluorescent effects. All 5 compounds selectively inhibited LARG-stimulated RhoA [35S] GTP S binding but had little to no effect on RhoA or G o [35S] GTP S binding. Therefore, these 5 compounds should serve as promising starting points for the development of small-molecule inhibitors of LARG-mediated nucleotide exchange as both pharmacological tools and therapeutics. In addition, the fluorescence polarization guanine nucleotide-binding assay described here should serve as a useful approach for both high-throughput screening and general biological applications. (Journal of Biomolecular Screening XXXX:xx-xx)
First published on February 4, 2009, doi:10.1177/1087057108328761 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S (BODIPY-TR-GTP
o [35S] GTP